Publication date: Jan 22, 2025
The median treatment duration was 224 (IQR, 189-289) days, and 7% of the overall cohort did not complete treatment. Patients who died of HIV coinfection were younger overall (mean age, 49. 6 years) at the time of post-treatment mortality. The researchers noted similar post-treatment mortality rates between patients who completed treatment and those who did not (both 7%). Eligible study patients included those aged 18 years and older who had a bacteriologic or clinical diagnosis of pulmonary or extrapulmonary TB disease. The researchers performed survival analyses among the cohort to determine risk factors for post-treatment mortality. Patients who died before or during TB treatment were excluded.
Concepts | Keywords |
---|---|
December | Alcohol |
Diabetes | Born |
Georgia | Care |
Hispanic | Ci |
Researchers | Cohort |
Coinfection | |
Comprehensive | |
Hiv | |
Hr | |
Mortality | |
Population | |
Post | |
Risk | |
Treatment | |
Years |
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | malignancy |
disease | MESH | cardiovascular disease |
disease | MESH | end-stage kidney disease |
disease | IDO | history |
disease | MESH | pulmonary disease |
drug | DRUGBANK | Ethanol |
disease | MESH | HIV coinfection |
disease | MESH | Emerging Infectious Diseases |
disease | MESH | infection |
drug | DRUGBANK | Tropicamide |
pathway | KEGG | Tuberculosis |
disease | MESH | Tuberculosis |